Fluoxetine Versus Placebo In Advanced Cancer Outpatients: A Placebo-Controlled, Double-Masked Trial Of The Hoosier Oncology Group

Heather Jones, MD

University of Pennsylvania Cancer
Ultima Vez Modificado: 14 de mayo del 2001

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Dexamethasone Beats Placebo for Cancer-Related Fatigue

Aug 2, 2013

More effective for reducing cancer-related fatigue; improvements in QoL and physical distress

ASCO: Risks Greater for Double Versus Single Mastectomy

Sep 4, 2014

But the complication rate associated with breast cancer surgery and reconstruction is small

Everolimus Ups Survival in Carcinoid Syndrome

Nov 29, 2011

For patients with advanced neuroendocrine tumors, octreotide LAR + everolimus improves PFS